StockDrifts LogoStockDrifts

SK Bioscience 302440

Company
SK바이오사이언스SK Bioscience
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-03-24

SK Bioscience (302440) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for SK Bioscience is dated 2025-12-09; the most recent is 2026-03-24.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-03-24BUY주식매수선택권
김훈
Kim Hoon
Global Business Representative21.9K₩42,150+5.1%₩921M ($640K)
2026-01-01BUY신규선임
신지영
Jiyoung Shin
implementation11.3K₩48,000+4.2%₩541M ($376K)
2026-01-01BUY신규선임
배정진
Bae Jeong-jin
implementation1.0K₩48,000+4.2%₩49M ($34K)
2025-12-23BUY주식매수선택권
안재용
Jaeyong Ahn
CEO21.9K₩50,700-1.4%₩1.1B ($769K)
2025-12-09BUY주식매수선택권
김훈
Kim Hoon
Global Business Representative21.9K₩53,100-5.8%₩1.2B ($806K)

Frequently asked questions

Who has been buying SK Bioscience stock?
0 distinct insiders have filed 0 disclosed insider purchases in SK Bioscience (302440), most recently on 2026-03-24. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does SK Bioscience have?
SK Bioscience has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-12-09 to 2026-03-24.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.